News & Analysis on Clinical Trial Services & Contract Research And Development
Bruker BioSpin has launched the world's highest field actively shielded NMR magnet at 950 MHz, which allows higher sensitivity and unrivalled spectral dispersion whilst maintaining same size cryostat and identical cryogenic performance as the 900 US2.
Greiner Bio-One presents its cell culture AutoFlask at the Analytica show, which uses a robot accessible entry septum that prevents coring by pipette tips and ensures sterility of the flask contents throughout solution exchanges.
Ilypsa has completed the first stage of its novel phosphate-binding agent designed to treat hyperphosphatemia, as the company plough forward with its pioneering research into next-generation nonabsorbed polymeric drugs for renal and metabolic disorders.
Covance has made a major expansion in its US Phase I/IIa drug development capabilities, buying eight early-phase clinical development sites from Radiant Research, who now plans to focus on its Phase II-IV business.
Outsourcing-Pharma focus on: Phase IIIB-IV research
The US Food & Drug Administration (FDA) is investigating ways of boosting the completion rate of new drug post marketing commitment studies in the wake of ongoing controversy over the agency's lack of enforcement. The answer, however, may already lie...
Perbio Science took the opportunity to provide a company update at this year's Analytica show in Munich with details of new product launches for drug discovery.